Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study.
Stoter
G
G
Rotterdam Cancer Institute, The Netherlands.
Fosså
S D
SD
Rugarli
C
C
Symann
M
M
Jasmin
C
C
Israel
L
L
Bijman
J T
JT
Palmer
P
P
Franks
C R
CR
Philip
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011379:Prognosis
D007376:Interleukin-2